Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Debra Freeman"'
Autor:
Laura Van Althuis, Sally Taylor, Debra Freeman, Stephanie Freel, Lynn Sutton, Kenisha Bethea, Leatrice Martin, Amanda McMillan, Diane Williams Garber, Keisha Bentley-Edwards, Nadine Barrett, Denise C. Snyder, Susanna Naggie
Publikováno v:
Journal of Clinical and Translational Science, Pp 1-16
Externí odkaz:
https://doaj.org/article/8f646975b7f444ad9e7654a25875cc47
Autor:
Michael L. Steinberg, Debra Freeman, Christopher R. King, Jason Wang, Giampaolo Bolzicco, Patrick A. Kupelian, Sean P. Collins, Irving D. Kaplan, Robert J. Meier, Donald B. Fuller, Alan W. Katz
Publikováno v:
Radiotherapy and Oncology. 109:217-221
PurposeThe effectiveness of stereotactic body radiotherapy (SBRT) for localized prostate cancer is tested.Methods and materialsA total of 1100 patients with clinically localized prostate cancer were enrolled in separate prospective phase 2 clinical t
Publikováno v:
Frontiers in Oncology
Title: Multi-institutional Registry for Prostate Cancer Radiosurgery: An Observational Clinical Trial Authors: Debra Freeman, MD*; Gregg Dickerson, MD; Mark Perman, MD Objective: To report on the design, methodology and early outcome results of a mul
Autor:
Debra Freeman
Publikováno v:
Journal of Clinical Oncology. 33:98-98
98 Background: To report on the design, methodology and early outcome results of a multi-institutional registry study of prostate cancer radiosurgery. Methods: The Registry for Prostate Cancer Radiosurgery (RPCR) was established in 2010 to further ev
Autor:
Sean P. Collins, Giampaolo Bolzicco, Patrick A. Kupelian, Irving D. Kaplan, Alan J. Katz, Robert J. Meier, Jason J. Wang, Donald B. Fuller, Christopher R. King, Debra Freeman
Publikováno v:
Journal of Clinical Oncology. 31:9-9
9 Background: The purpose of this study is to report biochemical relapse-free survival (bRFS) rates for a group of localized prostate cancer patients from a pooled multi-institutional dataset with at least 5 years follow-up after stereotactic body ra
Autor:
Debra Freeman, Christopher R. King
Publikováno v:
Radiation Oncology, Vol 6, Iss 1, p 3 (2011)
Freeman, Debra E; & King, Christopher R. (2011). Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes. Radiation Oncology, 6(1), 3. doi: http://dx.doi.org/10.1186/1748-717X-6-3. Retrieved from: http://www.escholarship.org/uc/item/9kf8830q
Radiation Oncology (London, England)
Freeman, Debra E; & King, Christopher R. (2011). Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes. Radiation Oncology, 6(1), 3. doi: http://dx.doi.org/10.1186/1748-717X-6-3. Retrieved from: http://www.escholarship.org/uc/item/9kf8830q
Radiation Oncology (London, England)
94 Background: Hypofractionated, stereotactic body radiotherapy (SBRT) is an emerging treatment approach for prostate cancer. We present the outcomes for low-risk prostate cancer patients with a median follow-up of 5 years after SBRT. Methods: Betwee
Autor:
Parthan, Anju, Pruttivarasin, Narin, Davies, Diane, Taylor, Douglas C. A, Pawar, Vivek, Bijlani, Akash, Lich, Kristen Hassmiller, Chen, Ronald C., Collins, Sean, Debra Freeman
Publikováno v:
Frontiers in Oncology; Aug2012, Vol. 2, p1-9, 9p
Autor:
Anthony S. Manoguerra, Debra Freeman
Publikováno v:
Journal of toxicology. Clinical toxicology. 19(8)
A case is presented of a 76-year-old male who ingested Nicotiana glauca and developed severe nicotine-alkaloid toxicity primarily characterized by neuromuscular blockade and respiratory failure. Recovery occurred with supportive care.